[go: up one dir, main page]

CN111606848A - A kind of preparation method of fluorodiphenyl substituted pyridine compounds - Google Patents

A kind of preparation method of fluorodiphenyl substituted pyridine compounds Download PDF

Info

Publication number
CN111606848A
CN111606848A CN202010507040.0A CN202010507040A CN111606848A CN 111606848 A CN111606848 A CN 111606848A CN 202010507040 A CN202010507040 A CN 202010507040A CN 111606848 A CN111606848 A CN 111606848A
Authority
CN
China
Prior art keywords
reaction
catalyst
crude product
ethanol
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010507040.0A
Other languages
Chinese (zh)
Inventor
申利群
吴爱群
鲁家豪
雷福厚
姚兴东
李文
杨珺
赖无忌
祁婉玲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangxi University for Nationalities
Original Assignee
Guangxi University for Nationalities
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangxi University for Nationalities filed Critical Guangxi University for Nationalities
Priority to CN202010507040.0A priority Critical patent/CN111606848A/en
Publication of CN111606848A publication Critical patent/CN111606848A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • C07D213/85Nitriles in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)

Abstract

The invention discloses a preparation method of a fluorodiphenyl substituted pyridine compound, which comprises the following steps: s1 adding NKC-9 catalyst, 4-hydroxyacetophenone, 2-trifluoromethylbenzaldehyde and appropriate amount of CHCl3 into a round bottom flask, heating and refluxing under the protection of nitrogen, tracking the reaction by TLC, filtering out the catalyst after the reaction is finished, washing the catalyst by using a small amount of chloroform, concentrating the filtrate to obtain a crude product, and recrystallizing by using 95% ethanol to obtain a chalcone precursor compound; adding the product of the last step, malononitrile and ammonium acetate into a round-bottom flask according to a molar ratio of 1:1: 3. The compound of the invention takes substituted acetophenone, substituted benzaldehyde, malononitrile, ethyl cyanoacetate and ammonium acetate as raw materials, a one-pot method is adopted to synthesize the 4, 6-diphenyl-3 cyanopyridine compound, and MTT (methyl thiazolyl tetrazolium) method tests show that the compound has strong inhibition effect on the proliferation of glioma U251 and has good application prospect in screening antitumor drugs.

Description

一种氟二苯基取代吡啶类化合物的制备方法A kind of preparation method of fluorodiphenyl substituted pyridine compounds

技术领域technical field

本发明涉及化合物制备技术领域,尤其涉及一种氟二苯基取代吡啶类化合物的制备方法。The invention relates to the technical field of compound preparation, in particular to a preparation method of a fluorodiphenyl substituted pyridine compound.

背景技术Background technique

有机配体与金属离子之间通过配位作用以及弱相互作用来构筑结构新颖、性能独特的配位聚合物,已经成为配位化学、超分子化学、晶体工程、材料化学领域的热点研究。利用配位化学特有的成键方式设计并合成新型配位聚合物材料,已成为配位化学与材料化学共同发展的方向。The coordination and weak interaction between organic ligands and metal ions to construct coordination polymers with novel structures and unique properties has become a hot research topic in the fields of coordination chemistry, supramolecular chemistry, crystal engineering, and materials chemistry. Designing and synthesizing new coordination polymer materials by using the unique bonding method of coordination chemistry has become a common development direction of coordination chemistry and materials chemistry.

本发明的化合物以取代苯乙酮,取代苯甲醛,丙二腈,氰乙酸乙酯,醋酸铵为原料,采用一锅法,合成4,6-二苯基-3氰基吡啶类化合物,经过MTT法测试,发现该药物对脑胶质瘤U251的增殖有很强的抑制作用,在筛选抗肿瘤药物上具有良好的应用前景。The compound of the present invention uses substituted acetophenone, substituted benzaldehyde, malononitrile, ethyl cyanoacetate, and ammonium acetate as raw materials, and adopts a one-pot method to synthesize 4,6-diphenyl-3 cyanopyridine compounds. The MTT method test showed that the drug has a strong inhibitory effect on the proliferation of glioma U251, and has a good application prospect in the screening of anti-tumor drugs.

发明内容SUMMARY OF THE INVENTION

基于背景技术存在的技术问题,本发明提出了一种氟二苯基取代吡啶类化合物的制备方法。Based on the technical problems existing in the background art, the present invention proposes a preparation method of fluorodiphenyl substituted pyridine compounds.

本发明提出的一种氟二苯基取代吡啶类化合物的制备方法,包括步骤如下:The preparation method of a kind of fluorodiphenyl substituted pyridine compound proposed by the present invention comprises the following steps:

S1在圆底烧瓶中加入NKC-9催化剂、4-羟基苯乙酮、2-三氟甲基苯甲醛、加入适量的CHCl3在氮气保护下加热回流,TLC跟踪反应,反应结束后,滤出催化剂用少量氯仿洗涤,滤液经浓缩得粗产品,再用 95%乙醇重结晶得到查尔酮前体化合物;S1 Add NKC-9 catalyst, 4-hydroxyacetophenone, 2-trifluoromethylbenzaldehyde to a round-bottomed flask, add an appropriate amount of CHCl3, heat to reflux under nitrogen protection, follow the reaction by TLC, after the reaction is over, filter out the catalyst Wash with a small amount of chloroform, and concentrate the filtrate to obtain a crude product, which is then recrystallized with 95% ethanol to obtain a chalcone precursor compound;

将上一步的产物与丙二腈、醋酸铵按照1:1:3的摩尔比加入到圆底烧瓶中,加入适量的无水乙醇在氮气保护下加热回流,TLC跟踪反应.反应结束后,浓缩的到反应后混合物,用乙酸乙酯:水=1:1萃取反应后的混合物,将乙酸乙酯蒸干得到粗品,将粗品在乙醇中重结晶得到目标产物,其名称为2-氨基-6-(4-羟基苯基)-4(2-三氟甲基苯基)-3-氰基吡啶,简称1a;The product of the previous step, malononitrile and ammonium acetate were added to a round-bottomed flask according to a molar ratio of 1:1:3, an appropriate amount of absolute ethanol was added, heated to reflux under nitrogen protection, and the reaction was followed by TLC. After the reaction was completed, concentrated to the reaction mixture, extract the reaction mixture with ethyl acetate:water=1:1, evaporate the ethyl acetate to dryness to obtain the crude product, and recrystallize the crude product in ethanol to obtain the target product, which is named 2-amino-6 -(4-Hydroxyphenyl)-4(2-trifluoromethylphenyl)-3-cyanopyridine, referred to as 1a;

S2在圆底烧瓶中加入NKC-9催化剂、4-羟基苯乙酮、3-三氟甲基苯甲醛、加入适量的CHCl3在氮气保护下加热回流,TLC跟踪反应,反应结束后,滤出催化剂用少量氯仿洗涤,滤液经浓缩得粗产品,再用 95%乙醇重结晶得到查尔酮前体化合物;S2 Add NKC-9 catalyst, 4-hydroxyacetophenone, 3-trifluoromethylbenzaldehyde to the round-bottomed flask, add an appropriate amount of CHCl3, heat to reflux under nitrogen protection, follow the reaction by TLC, after the reaction is over, filter out the catalyst Wash with a small amount of chloroform, and concentrate the filtrate to obtain a crude product, which is then recrystallized with 95% ethanol to obtain a chalcone precursor compound;

将上一步的产物与丙二腈、醋酸铵按照1:1:3的摩尔比加入到圆底烧瓶中,加入适量的无水乙醇在氮气保护下加热回流,TLC跟踪反应,反应结束后,浓缩的到反应后混合物,用乙酸乙酯:水=1:1萃取反应后的混合物,将乙酸乙酯蒸干得到粗品,将粗品在乙醇中重结晶得到目标产物,其名称为2-氨基-6-(4-羟基苯基)-4(3-三氟甲基苯基)-3-氰基吡啶,简称2a;The product of the previous step, malononitrile and ammonium acetate were added to a round-bottomed flask in a molar ratio of 1:1:3, an appropriate amount of anhydrous ethanol was added, heated to reflux under nitrogen protection, and the reaction was followed by TLC. After the reaction was completed, concentrated to the reaction mixture, extract the reaction mixture with ethyl acetate:water=1:1, evaporate the ethyl acetate to dryness to obtain the crude product, and recrystallize the crude product in ethanol to obtain the target product, which is named 2-amino-6 -(4-Hydroxyphenyl)-4(3-trifluoromethylphenyl)-3-cyanopyridine, referred to as 2a;

S3在圆底烧瓶中加入NKC-9催化剂、2,4-二氟苯乙酮、4-羟基苯甲醛、加入适量的CHCl3在氮气保护下加热回流,TLC跟踪反应,反应结束后,滤出催化剂用少量氯仿洗涤,滤液经浓缩得粗产品,再用95%乙醇重结晶得到查尔酮前体化合物;S3 Add NKC-9 catalyst, 2,4-difluoroacetophenone, 4-hydroxybenzaldehyde to a round-bottomed flask, add an appropriate amount of CHCl3, heat to reflux under nitrogen protection, follow the reaction by TLC, after the reaction is over, filter out the catalyst Wash with a small amount of chloroform, and concentrate the filtrate to obtain a crude product, which is then recrystallized with 95% ethanol to obtain a chalcone precursor compound;

将上一步的产物与丙二腈、醋酸铵按照1:1:3的摩尔比加入到圆底烧瓶中,加入适量的无水乙醇在氮气保护下加热回流,TLC跟踪反应.反应结束后,浓缩的到反应后混合物,用乙酸乙酯:水=1:1萃取反应后的混合物,将乙酸乙酯蒸干得到粗品,将粗品在乙醇中重结晶得到目标产物,其名称为2-氨基-6-(2,4-二氟苯基)-4-(4-羟基甲基苯基)-3-氰基吡啶,简称3a;The product of the previous step, malononitrile and ammonium acetate were added to a round-bottomed flask according to a molar ratio of 1:1:3, an appropriate amount of absolute ethanol was added, heated to reflux under nitrogen protection, and the reaction was followed by TLC. After the reaction was completed, concentrated to the reaction mixture, extract the reaction mixture with ethyl acetate:water=1:1, evaporate the ethyl acetate to dryness to obtain the crude product, and recrystallize the crude product in ethanol to obtain the target product, which is named 2-amino-6 -(2,4-Difluorophenyl)-4-(4-hydroxymethylphenyl)-3-cyanopyridine, referred to as 3a;

S4在圆底烧瓶中加入NKC-9催化剂、2,4-二氟苯乙酮、4-羟基苯甲醛、加入适量的CHCl3在氮气保护下加热回流,TLC跟踪反应,反应结束后,滤出催化剂用少量氯仿洗涤,滤液经浓缩得粗产品,再用 95%乙醇重结晶得到查尔酮前体化合物;将上一步的产物与氰乙酸乙酯、醋酸铵按照1:1:3的摩尔比加入到圆底烧瓶中,加入适量的无水乙醇在氮气保护下加热回流,TLC跟踪反应.反应结束后,浓缩的到反应后混合物,用乙酸乙酯:水=1:1萃取反应后的混合物,将乙酸乙酯蒸干得到粗品,将粗品在乙醇中重结晶得到目标产物,其名称为2-氨基-6-(2,4-二氟苯基)-4-(4-羟基甲基苯基)-2氧代-1,2-二氢-3氰基吡啶,简称4a。S4 Add NKC-9 catalyst, 2,4-difluoroacetophenone, 4-hydroxybenzaldehyde to a round-bottomed flask, add an appropriate amount of CHCl3, heat to reflux under nitrogen protection, follow the reaction by TLC, after the reaction is over, filter out the catalyst Wash with a small amount of chloroform, and concentrate the filtrate to obtain a crude product, which is then recrystallized with 95% ethanol to obtain a chalcone precursor compound; the product of the previous step, ethyl cyanoacetate and ammonium acetate are added in a molar ratio of 1:1:3 Into a round-bottomed flask, add an appropriate amount of anhydrous ethanol, heat to reflux under nitrogen protection, follow the reaction by TLC. After the reaction is completed, concentrate the reaction mixture, extract the reaction mixture with ethyl acetate: water = 1:1, Evaporate the ethyl acetate to dryness to obtain the crude product, and recrystallize the crude product in ethanol to obtain the target product, whose name is 2-amino-6-(2,4-difluorophenyl)-4-(4-hydroxymethylphenyl) )-2oxo-1,2-dihydro-3 cyanopyridine, referred to as 4a.

优选的,所述NKC-9催化剂为大孔强酸性苯乙烯系阳离子交换树脂。Preferably, the NKC-9 catalyst is a macroporous strongly acidic styrene-based cation exchange resin.

本发明中,所述一种氟二苯基取代吡啶类化合物的制备方法,本发明的化合物以取代苯乙酮,取代苯甲醛,丙二腈,氰乙酸乙酯,醋酸铵为原料,采用一锅法,合成4,6-二苯基-3氰基吡啶类化合物,经过MTT法测试,发现该药物对脑胶质瘤U251的增殖有很强的抑制作用,在筛选抗肿瘤药物上具有良好的应用前景。In the present invention, for the preparation method of a fluorodiphenyl substituted pyridine compound, the compound of the present invention uses substituted acetophenone, substituted benzaldehyde, malononitrile, ethyl cyanoacetate and ammonium acetate as raw materials, and adopts a The pot method was used to synthesize 4,6-diphenyl-3 cyanopyridine compounds. After the MTT method, it was found that the drug has a strong inhibitory effect on the proliferation of glioma U251, and it has a good effect in screening anti-tumor drugs. application prospects.

具体实施方式Detailed ways

下面将对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。The technical solutions in the embodiments of the present invention will be described clearly and completely below. Obviously, the described embodiments are only a part of the embodiments of the present invention, rather than all the embodiments.

实施例一Example 1

2-氨基-6-(4-羟基苯基)-4(2-三氟甲基苯基)-3-氰基吡啶其合成路线如下:The synthetic route of 2-amino-6-(4-hydroxyphenyl)-4(2-trifluoromethylphenyl)-3-cyanopyridine is as follows:

Figure RE-GDA0002580557740000041
Figure RE-GDA0002580557740000041

称取4-羟基苯乙酮(408mg,3mmol),2-三氟甲基苯甲醛 (522mg3mmol),0.4gNKC-9催化剂加入到圆底烧瓶中,加入5ml氯仿溶解,冲入氮气保护,回流反应,TLC监测反应进程,待反应完全后,冷却到室温,过滤出NKC-9催化剂,将滤液浓缩得到中间体的粗产物,将中间体的粗产物用95%的乙醇重结晶,得到中间体的纯品。Weigh 4-hydroxyacetophenone (408mg, 3mmol), 2-trifluoromethylbenzaldehyde (522mg3mmol), add 0.4g NKC-9 catalyst to the round-bottomed flask, add 5ml chloroform to dissolve, rush into nitrogen protection, reflux reaction , TLC monitors the reaction progress, after the reaction is complete, cool to room temperature, filter out the NKC-9 catalyst, concentrate the filtrate to obtain the crude product of the intermediate, and recrystallize the crude product of the intermediate with 95% ethanol to obtain the crude product of the intermediate. Pure.

Figure RE-GDA0002580557740000051
Figure RE-GDA0002580557740000051

称取中间体3mmol,丙二腈(198mg,3mmol),醋酸铵(514mg, 9mmol)加入到圆底烧瓶中,加入20ml无水乙醇,冲入氮气保护,回流反应8h,TLC监测反应进程,待反应完全,浓缩得到反应后混合物,用乙酸乙酯:水=1:1萃取反应后的混合物,将乙酸乙酯蒸干得到粗品,将粗品在乙醇中重结晶得到目标产物。Weigh intermediate 3mmol, malononitrile (198mg, 3mmol), ammonium acetate (514mg, 9mmol) were added to the round-bottomed flask, 20ml absolute ethanol was added, nitrogen protection was added, and the reaction was refluxed for 8h. After the reaction is complete, concentrate to obtain the reaction mixture, extract the reaction mixture with ethyl acetate: water = 1:1, evaporate the ethyl acetate to dryness to obtain the crude product, and recrystallize the crude product in ethanol to obtain the target product.

其名称为2-氨基-6-(4-羟基苯基)-4(2-三氟甲基苯基)-3- 氰基吡啶,简称1a,其结构式如下:Its name is 2-amino-6-(4-hydroxyphenyl)-4(2-trifluoromethylphenyl)-3-cyanopyridine, referred to as 1a, and its structural formula is as follows:

Figure RE-GDA0002580557740000052
Figure RE-GDA0002580557740000052

产品1a为淡黄色粉末固体(产率43%),核磁1HNMR(400MHz, DMSO-d6)δ9.97(s,1H),8.13–8.03(m,0H),8.00–7.88 (m,2H),7.82(td,J=7.8,1.3Hz,1H),7.78–7.68(m,1H), 7.64(s,0H),7.57–7.49(m,1H),7.08(s,1H),7.01(s,1H), 6.94–6.82(m,2H).13CNMR(101MHz,DMSO-d6)δ160.17, 158.42,153.36,136.55,133.12,131.36,130.01,129.39,128.64, 128.47,126.72,116.74,115.96,109.12,87.60。Product 1a is a pale yellow powder solid (yield 43%), 1HNMR (400MHz, DMSO-d6)δ9.97(s,1H), 8.13–8.03(m,0H), 8.00–7.88 (m,2H), 7.82(td, J=7.8, 1.3Hz, 1H), 7.78-7.68(m, 1H), 7.64(s, 0H), 7.57-7.49(m, 1H), 7.08(s, 1H), 7.01(s, 1H), 6.94–6.82(m, 2H).13CNMR(101MHz,DMSO-d6)δ160.17, 158.42,153.36,136.55,133.12,131.36,130.01,129.39,128.64, 128.47,126.72,116.74,115 87.60.

实例二Example 2

2-氨基-6-(4-羟基苯基)-4(3-三氟甲基苯基)-3-氰基吡啶2-Amino-6-(4-hydroxyphenyl)-4(3-trifluoromethylphenyl)-3-cyanopyridine

其合成路线如下:Its synthetic route is as follows:

Figure RE-GDA0002580557740000061
Figure RE-GDA0002580557740000061

称取4-羟基苯乙酮(408mg,3mmol),3-三氟甲基苯甲醛 (522mg3mmol),0.4gNKC-9催化剂加入到圆底烧瓶中,加入5ml氯仿溶解,冲入氮气保护,回流反应,TLC监测反应进程,待反应完全后,冷却到室温,过滤出NKC-9催化剂,将滤液浓缩得到中间体的粗产物,将中间体的粗产物用95%的乙醇重结晶,得到中间体的纯品。4-Hydroxyacetophenone (408mg, 3mmol), 3-trifluoromethylbenzaldehyde (522mg3mmol), 0.4g NKC-9 catalyst were weighed into the round-bottomed flask, 5ml of chloroform was added to dissolve, flushed into nitrogen protection, and refluxed for reaction , TLC monitors the reaction progress, after the reaction is complete, cool to room temperature, filter out the NKC-9 catalyst, concentrate the filtrate to obtain the crude product of the intermediate, and recrystallize the crude product of the intermediate with 95% ethanol to obtain the crude product of the intermediate. Pure.

Figure RE-GDA0002580557740000062
Figure RE-GDA0002580557740000062

称取中间体3mmol,丙二腈(198mg,3mmol),醋酸铵(514mg, 9mmol)加入到圆底烧瓶中,加入20ml无水乙醇,冲入氮气保护,回流反应8h,TLC监测反应进程,待反应完全,浓缩得到反应后混合物,用乙酸乙酯:水=1:1萃取反应后的混合物,将乙酸乙酯蒸干得到粗品,将粗品在乙醇中重结晶得到目标产物。Weigh intermediate 3mmol, malononitrile (198mg, 3mmol), ammonium acetate (514mg, 9mmol) were added to the round-bottomed flask, 20ml absolute ethanol was added, nitrogen protection was added, and the reaction was refluxed for 8h. After the reaction is complete, concentrate to obtain the reaction mixture, extract the reaction mixture with ethyl acetate: water = 1:1, evaporate the ethyl acetate to dryness to obtain the crude product, and recrystallize the crude product in ethanol to obtain the target product.

其名称为2-氨基-6-(4-羟基苯基)-4(3-三氟甲基苯基)-3- 氰基吡啶,简称2a,其结构式如下:Its name is 2-amino-6-(4-hydroxyphenyl)-4(3-trifluoromethylphenyl)-3-cyanopyridine, referred to as 2a, and its structural formula is as follows:

Figure RE-GDA0002580557740000071
Figure RE-GDA0002580557740000071

产品2a为淡黄色固体(产率42%),核磁1HNMR(400MHz, DMSO-d6)δ9.97(s,1H),8.08–7.96(m,4H),7.94–7.88 (m,1H),7.80(t,J=7.8Hz,1H),7.27(s,1H),7.01(s,2H),6.90–6.85(m,2H)。Product 2a is a pale yellow solid (yield 42%), 1HNMR (400MHz, DMSO-d6)δ9.97(s,1H), 8.08–7.96(m,4H), 7.94–7.88 (m,1H), 7.80 (t, J=7.8 Hz, 1H), 7.27 (s, 1H), 7.01 (s, 2H), 6.90–6.85 (m, 2H).

13CNMR(101MHz,DMSO-d6)δ161.20,160.15,159.38, 138.60,133.04,130.32,129.56,128.87,128.67,126.57(d,J =3.9Hz),125.53(d,J=4.0Hz),117.54,115.86,108.74,85.62。13CNMR(101MHz,DMSO-d6)δ161.20,160.15,159.38,138.60,133.04,130.32,129.56,128.87,128.67,126.57(d,J=3.9Hz),125.53(d,J=4.0Hz),117.54,115 108.74, 85.62.

实例三Example three

2-氨基-6-(2,4-二氟苯基)-4-(4-羟基甲基苯基)-3-氰基吡啶;2-amino-6-(2,4-difluorophenyl)-4-(4-hydroxymethylphenyl)-3-cyanopyridine;

其合成路线如下:Its synthetic route is as follows:

Figure RE-GDA0002580557740000081
Figure RE-GDA0002580557740000081

称取2,4-二氟苯乙酮(408mg,3mmol),4-羟基苯甲醛 (522mg3mmol),0.4gNKC-9催化剂加入到圆底烧瓶中,加入5ml氯仿溶解,冲入氮气保护,回流反应,TLC监测反应进程,待反应完全后,冷却到室温,过滤出NKC-9催化剂,将滤液浓缩得到中间体的粗产物,将中间体的粗产物用95%的乙醇重结晶,得到中间体的纯品。Weigh 2,4-difluoroacetophenone (408mg, 3mmol), 4-hydroxybenzaldehyde (522mg3mmol), add 0.4g NKC-9 catalyst to the round bottom flask, add 5ml chloroform to dissolve, flush with nitrogen protection, reflux reaction , TLC monitors the reaction progress, after the reaction is complete, cool to room temperature, filter out the NKC-9 catalyst, concentrate the filtrate to obtain the crude product of the intermediate, and recrystallize the crude product of the intermediate with 95% ethanol to obtain the crude product of the intermediate. Pure.

Figure RE-GDA0002580557740000082
Figure RE-GDA0002580557740000082

称取中间体3mmol,丙二腈(198mg,3mmol),醋酸铵(514mg, 9mmol)加入到圆底烧瓶中,加入20ml无水乙醇,冲入氮气保护,回流反应8h,TLC监测反应进程,待反应完全,浓缩得到反应后混合物,用乙酸乙酯:水=1:1萃取反应后的混合物,将乙酸乙酯蒸干得到粗品,将粗品在乙醇中重结晶得到目标产物。Weigh intermediate 3mmol, malononitrile (198mg, 3mmol), ammonium acetate (514mg, 9mmol) were added to the round-bottomed flask, 20ml absolute ethanol was added, nitrogen protection was added, and the reaction was refluxed for 8h. After the reaction is complete, concentrate to obtain the reaction mixture, extract the reaction mixture with ethyl acetate: water = 1:1, evaporate the ethyl acetate to dryness to obtain the crude product, and recrystallize the crude product in ethanol to obtain the target product.

其名称为2-氨基-6-(2,4-二氟苯基)-4-(4-羟基甲基苯基) -3-氰基吡啶,简称3a,其结构式如下:Its name is 2-amino-6-(2,4-difluorophenyl)-4-(4-hydroxymethylphenyl)-3-cyanopyridine, referred to as 3a, and its structural formula is as follows:

Figure RE-GDA0002580557740000091
Figure RE-GDA0002580557740000091

产品3a为白色固体(产率40%),核磁1HNMR(400MHz,DMSO-d6) δ10.00(d,J=1.3Hz,1H),8.06–7.80(m,1H),7.51(dd, J=8.4,1.6Hz,2H),7.39(ddd,J=11.7,9.2,2.4Hz,1H), 7.26(td,J=8.5,2.3Hz,1H),7.10–6.98(m,3H),6.99– 6.87(m,2H).13CNMR(101MHz,DMSO-d6)δ161.38,159.52, 155.10,154.50,133.52–131.96(m),130.24,127.60,124.05 –122.29(m),117.58,116.08,113.30–112.19(m),105.22(t, J=26.8Hz),87.21。Product 3a is a white solid (yield 40%), 1H NMR (400MHz, DMSO-d6) δ10.00 (d, J=1.3Hz, 1H), 8.06-7.80 (m, 1H), 7.51 (dd, J= 8.4, 1.6Hz, 2H), 7.39 (ddd, J=11.7, 9.2, 2.4Hz, 1H), 7.26 (td, J=8.5, 2.3Hz, 1H), 7.10–6.98 (m, 3H), 6.99– 6.87 (m,2H).13CNMR(101MHz,DMSO-d6)δ161.38,159.52,155.10,154.50,133.52–131.96(m),130.24,127.60,124.05–122.29(m),117.58,116.08,113.30–112.19(m) , 105.22(t, J=26.8Hz), 87.21.

实例四Example 4

2-氨基-6-(2,4-二氟苯基)-4-(4-羟基甲基苯基)-2氧代-1,2- 二氢-3氰基吡啶2-Amino-6-(2,4-difluorophenyl)-4-(4-hydroxymethylphenyl)-2oxo-1,2-dihydro-3cyanopyridine

去合成路线如下:The synthetic route is as follows:

Figure RE-GDA0002580557740000101
Figure RE-GDA0002580557740000101

称取2,4-二氟苯乙酮(408mg,3mmol),4-羟基苯甲醛 (522mg3mmol),0.4gNKC-9催化剂加入到圆底烧瓶中,加入5ml氯仿溶解,冲入氮气保护,回流反应,TLC监测反应进程,待反应完全后,冷却到室温,过滤出NKC-9催化剂,将滤液浓缩得到中间体的粗产物,将中间体的粗产物用95%的乙醇重结晶,得到中间体的纯品Weigh 2,4-difluoroacetophenone (408mg, 3mmol), 4-hydroxybenzaldehyde (522mg3mmol), add 0.4g NKC-9 catalyst to the round bottom flask, add 5ml chloroform to dissolve, flush with nitrogen protection, reflux reaction , TLC monitors the reaction progress, after the reaction is complete, cool to room temperature, filter out the NKC-9 catalyst, concentrate the filtrate to obtain the crude product of the intermediate, and recrystallize the crude product of the intermediate with 95% ethanol to obtain the crude product of the intermediate. Pure

Figure RE-GDA0002580557740000102
Figure RE-GDA0002580557740000102

称取中间体3mmol,氰乙酸乙酯(340mg,3mmol),醋酸铵(514mg, 9mmol)加入到圆底烧瓶中,加入20ml无水乙醇,冲入氮气保护,回流反应8h,TLC监测反应进程,待反应完全,浓缩得到反应后混合物,用乙酸乙酯:水=1:1萃取反应后的混合物,将乙酸乙酯蒸干得到粗品,将粗品在乙醇中重结晶得到目标产物。Weighing intermediate 3mmol, ethyl cyanoacetate (340mg, 3mmol), ammonium acetate (514mg, 9mmol) were added to the round-bottomed flask, 20ml of absolute ethanol was added, nitrogen protection was added, the reaction was refluxed for 8h, and the reaction progress was monitored by TLC, After the reaction is complete, concentrate to obtain the reacted mixture, extract the reacted mixture with ethyl acetate:water=1:1, evaporate the ethyl acetate to dryness to obtain the crude product, and recrystallize the crude product in ethanol to obtain the target product.

其名称为2-氨基-6-(2,4-二氟苯基)-4-(4-羟基甲基苯基) -2氧代-1,2-二氢-3氰基吡啶,简称4a,其结构式如下:Its name is 2-amino-6-(2,4-difluorophenyl)-4-(4-hydroxymethylphenyl)-2oxo-1,2-dihydro-3 cyanopyridine, referred to as 4a , and its structure is as follows:

Figure RE-GDA0002580557740000111
Figure RE-GDA0002580557740000111

产品4a为白色固体(产率45%),核磁1HNMR(400MHz,DMSO-d6) δ12.77(s,1H),10.18(s,1H),7.81(td,J=8.6,6.4Hz,1H), 7.71–7.58(m,2H),7.49(ddd,J=11.4,9.3,2.5Hz,1H), 7.28(td,J=8.5,2.6Hz,1H),7.05–6.89(m,2H),6.63(s, 1H).13CNMR(101MHz,DMSO-d6)δ165.38(d,J=12.7Hz), 162.89(d,J=12.4Hz),162.19,161.36(d,J=12.9Hz),160.40, 158.84(d,J=13.0Hz),132.95(dd,J=10.4,3.5Hz),130.62, 126.49,118.42,117.23,116.09,112.69(dd,J=21.7,3.5Hz), 108.68,105.36(t,J=26.2Hz),98.61。Product 4a is a white solid (yield 45%), nuclear magnetic 1HNMR (400MHz, DMSO-d6) δ12.77 (s, 1H), 10.18 (s, 1H), 7.81 (td, J=8.6, 6.4Hz, 1H) , 7.71–7.58(m, 2H), 7.49(ddd, J=11.4, 9.3, 2.5Hz, 1H), 7.28(td, J=8.5, 2.6Hz, 1H), 7.05–6.89(m, 2H), 6.63 (s, 1H).13CNMR(101MHz,DMSO-d6)δ165.38(d,J=12.7Hz), 162.89(d,J=12.4Hz),162.19,161.36(d,J=12.9Hz),160.40, 158.84(d, J=13.0Hz), 132.95(dd, J=10.4, 3.5Hz), 130.62, 126.49, 118.42, 117.23, 116.09, 112.69(dd, J=21.7, 3.5Hz), 108.68, 105.36(t, J=26.2Hz), 98.61.

双苯基吡啶类化合物1-4的抗肿瘤效果;Antitumor effect of biphenylpyridine compounds 1-4;

选择u251为靶细胞,用10-羟基喜树碱为阳性药,用MTT比色法测定细胞的抗增殖效果。取0.25%胰蛋白酶消化单层培养的u251 细胞,用含有10%的胎牛血清的DEME培养基调成每毫升1*105的单细胞悬浮液,以每孔100ul接种于96孔板中。Select u251 as the target cell, use 10-hydroxycamptothecin as the positive drug, and measure the antiproliferative effect of the cells by MTT colorimetry. Take 0.25% trypsinized monolayer cultured u251 cells, adjust with DEME medium containing 10% fetal bovine serum to make a single cell suspension of 1*105 per ml, and inoculate 100ul per well in a 96-well plate.

培养板放入二氧化碳CO2培养箱,37℃,5%CO2饱和湿度条件下培养24h,待细胞贴壁后,吸出旧的培养基,分别加入含有40uM、20uM、 10uM、5uM、2.5uM待测药物和5%胎牛血清的培养基(),每个浓度设置设置5个复孔,实验设置空白组,继续放入CO2培养箱,37℃,5% CO2饱和湿度条件下培养48h;之后吸出培养基,每孔加入MTT(5mg/L) 20ul,继续放入CO2培养箱,37℃,5%CO2饱和湿度条件下培养1h;加入DMSO100ul,震荡溶解甲瓒沉淀,在酶联免疫检测仪上测定490nm 测量各个孔的吸光度(A)值,按公式:抑制率=(阴性对照组平均A值-给药组平均A值)/(对照组平均A值-空白对照组A值)*100%。The culture plate was placed in a carbon dioxide CO2 incubator, and incubated at 37°C under 5% CO2 saturated humidity conditions for 24 hours. After the cells adhered, the old medium was sucked out, and 40uM, 20uM, 10uM, 5uM, 2.5uM of the drug to be tested were added respectively. and 5% fetal bovine serum (FBS), 5 replicate wells were set for each concentration setting, and the experiment was set up as a blank group, and continued to be placed in a CO2 incubator, 37°C, and 5% CO2-saturated humidity for 48 hours; then aspirated and cultured base, add 20ul MTT (5mg/L) to each well, continue to put it in a CO2 incubator, incubate at 37°C, 5% CO2-saturated humidity for 1 h; add 100ul DMSO, shake to dissolve the formazan precipitate, and measure it on an enzyme-linked immunosorbent assay (ELISA) Measure the absorbance (A) value of each well at 490 nm, according to the formula: inhibition rate=(average A value of negative control group-average A value of administration group)/(average A value of control group-A value of blank control group)*100%.

计算化合物对细胞的抑制率Calculate the rate of inhibition of cells by compounds

表中为4,6-二苯基-3氰基吡啶类化合物抗肿瘤增殖活性The table shows the anti-tumor proliferation activity of 4,6-diphenyl-3 cyanopyridine compounds

化合物compound u251IC50(umol/l)u251IC50(umol/l) 10-羟基喜树碱10-Hydroxycamptothecin 55.3555.35 1a1a 23.0523.05 2a2a 17.6417.64 3a3a 6.036.03 4a4a 12.01 12.01

以上所述,仅为本发明较佳的具体实施方式,但本发明的保护范围并不局限于此,任何熟悉本技术领域的技术人员在本发明揭露的技术范围内,根据本发明的技术方案及其发明构思加以等同替换或改变,都应涵盖在本发明的保护范围之内。The above description is only a preferred embodiment of the present invention, but the protection scope of the present invention is not limited to this. The equivalent replacement or change of the inventive concept thereof shall be included within the protection scope of the present invention.

Claims (2)

1. A preparation method of a fluorodiphenyl substituted pyridine compound is characterized by comprising the following steps:
s1 adding NKC-9 catalyst, 4-hydroxyacetophenone, 2-trifluoromethylbenzaldehyde and appropriate amount of CHCl3 into a round bottom flask, heating and refluxing under the protection of nitrogen, tracking the reaction by TLC, filtering out the catalyst after the reaction is finished, washing the catalyst by using a small amount of chloroform, concentrating the filtrate to obtain a crude product, and recrystallizing by using 95% ethanol to obtain a chalcone precursor compound;
adding the product of the last step, malononitrile and ammonium acetate into a round-bottom flask according to a molar ratio of 1:1:3, adding a proper amount of absolute ethanol, heating and refluxing under the protection of nitrogen, tracking the reaction by TLC, concentrating to obtain a post-reaction mixture after the reaction is finished, and adding ethyl acetate: extracting the reacted mixture with 1:1, evaporating ethyl acetate to dryness to obtain a crude product, and recrystallizing the crude product in ethanol to obtain a target product, wherein the name of the target product is 2-amino-6- (4-hydroxyphenyl) -4 (2-trifluoromethylphenyl) -3-cyanopyridine, which is called 1a for short;
s2 adding NKC-9 catalyst, 4-hydroxyacetophenone, 3-trifluoromethylbenzaldehyde into a round-bottom flask, adding a proper amount of CHCl3, heating and refluxing under the protection of nitrogen, tracking the reaction by TLC, filtering out the catalyst after the reaction is finished, washing the catalyst by using a small amount of chloroform, concentrating the filtrate to obtain a crude product, and recrystallizing by using 95% ethanol to obtain a chalcone precursor compound;
adding the product of the last step, malononitrile and ammonium acetate into a round-bottom flask according to a molar ratio of 1:1:3, adding a proper amount of absolute ethanol, heating and refluxing under the protection of nitrogen, tracking the reaction by TLC, concentrating to obtain a post-reaction mixture after the reaction is finished, and adding ethyl acetate: extracting the reacted mixture with water at a ratio of 1:1, evaporating ethyl acetate to dryness to obtain a crude product, and recrystallizing the crude product in ethanol to obtain a target product, wherein the name of the target product is 2-amino-6- (4-hydroxyphenyl) -4 (3-trifluoromethylphenyl) -3-cyanopyridine, which is called 2a for short;
s3 adding an NKC-9 catalyst, 2, 4-difluoroacetophenone, 4-hydroxybenzaldehyde and a proper amount of CHCl3 into a round-bottom flask, heating and refluxing under the protection of nitrogen, tracking and reacting by TLC, filtering out the catalyst after the reaction is finished, washing the catalyst by using a small amount of chloroform, concentrating the filtrate to obtain a crude product, and recrystallizing by using 95% ethanol to obtain a chalcone precursor compound;
adding the product of the last step, malononitrile and ammonium acetate into a round-bottom flask according to a molar ratio of 1:1:3, adding a proper amount of absolute ethanol, heating and refluxing under the protection of nitrogen, tracking the reaction by TLC, concentrating to obtain a post-reaction mixture after the reaction is finished, and adding ethyl acetate: extracting the reacted mixture with 1:1, evaporating ethyl acetate to dryness to obtain a crude product, and recrystallizing the crude product in ethanol to obtain a target product, wherein the name of the target product is 2-amino-6- (2, 4-difluorophenyl) -4- (4-hydroxymethylphenyl) -3-cyanopyridine, which is called 3a for short;
s4 adding an NKC-9 catalyst, 2, 4-difluoroacetophenone, 4-hydroxybenzaldehyde and a proper amount of CHCl3 into a round-bottom flask, heating and refluxing under the protection of nitrogen, tracking and reacting by TLC, filtering out the catalyst after the reaction is finished, washing the catalyst by using a small amount of chloroform, concentrating the filtrate to obtain a crude product, and recrystallizing by using 95% ethanol to obtain a chalcone precursor compound; adding the product of the previous step, ethyl cyanoacetate and ammonium acetate into a round-bottom flask according to a molar ratio of 1:1:3, adding a proper amount of absolute ethyl alcohol, heating and refluxing under the protection of nitrogen, tracking the reaction by TLC, concentrating to obtain a post-reaction mixture, and adding ethyl acetate: extracting the reacted mixture with 1:1 of water, evaporating ethyl acetate to dryness to obtain a crude product, and recrystallizing the crude product in ethanol to obtain a target product, wherein the name of the target product is 2-amino-6- (2, 4-difluorophenyl) -4- (4-hydroxymethylphenyl) -2 oxo-1, 2-dihydro-3 cyanopyridine, which is 4a for short.
2. The method for preparing a fluorodiphenyl-substituted pyridine compound according to claim 1, wherein said NKC-9 catalyst is a macroporous strongly acidic styrene cation exchange resin.
CN202010507040.0A 2020-06-05 2020-06-05 A kind of preparation method of fluorodiphenyl substituted pyridine compounds Pending CN111606848A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010507040.0A CN111606848A (en) 2020-06-05 2020-06-05 A kind of preparation method of fluorodiphenyl substituted pyridine compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010507040.0A CN111606848A (en) 2020-06-05 2020-06-05 A kind of preparation method of fluorodiphenyl substituted pyridine compounds

Publications (1)

Publication Number Publication Date
CN111606848A true CN111606848A (en) 2020-09-01

Family

ID=72198454

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010507040.0A Pending CN111606848A (en) 2020-06-05 2020-06-05 A kind of preparation method of fluorodiphenyl substituted pyridine compounds

Country Status (1)

Country Link
CN (1) CN111606848A (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102827073A (en) * 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 Therapeutically active compositions and application methods thereof
CN102838536A (en) * 2012-09-25 2012-12-26 中国林业科学研究院林产化学工业研究所 3-cyanopyridine derivative and preparation as well as application thereof
CN102875462A (en) * 2012-10-11 2013-01-16 中国药科大学 Anti-tumor 2-amino nicotinonitrile, application and preparation method thereof
CN103804160A (en) * 2014-01-27 2014-05-21 南京运华立太能源科技有限公司 Preparation method of 3-methyl-3-amylene-2-ketone
CN109020883A (en) * 2018-03-27 2018-12-18 广西民族大学 A kind of 3- cyano -2-aminopyridine analog derivative and the preparation method and application thereof
CN109651341A (en) * 2017-10-11 2019-04-19 上海医药工业研究院 Phonetic (pyrrole) the pyridine analog derivative of dimorpholine cyano and as anti-tumor drug application

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102827073A (en) * 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 Therapeutically active compositions and application methods thereof
CN102838536A (en) * 2012-09-25 2012-12-26 中国林业科学研究院林产化学工业研究所 3-cyanopyridine derivative and preparation as well as application thereof
CN102875462A (en) * 2012-10-11 2013-01-16 中国药科大学 Anti-tumor 2-amino nicotinonitrile, application and preparation method thereof
CN103804160A (en) * 2014-01-27 2014-05-21 南京运华立太能源科技有限公司 Preparation method of 3-methyl-3-amylene-2-ketone
CN109651341A (en) * 2017-10-11 2019-04-19 上海医药工业研究院 Phonetic (pyrrole) the pyridine analog derivative of dimorpholine cyano and as anti-tumor drug application
CN109020883A (en) * 2018-03-27 2018-12-18 广西民族大学 A kind of 3- cyano -2-aminopyridine analog derivative and the preparation method and application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
AYA M. SERRY 等: ""One-Pot Synthesis of 4,6-Diaryl-2-oxo(imino)-1,2-dihydropyridine-3-carbonitrile; a New Scaffold for p38αMAP Kinase Inhibition"", 《J. COMB. CHEM.》 *

Similar Documents

Publication Publication Date Title
CN101941919B (en) Method for preparing derivatives of cis-oximes and oxime ethers
CN103608341B (en) N-aryl unsaturated condensed ring tertiary amine compounds and preparation method thereof and antitumor application
CN109438365B (en) N- (3- ((4-trifluoromethyl) -2-pyrimidinyl) aminophenyl) -2, 6-difluorobenzenesulfonamide derivative
CN113387892B (en) Imidazole heterocyclic derivative containing nitrogen mustard and preparation method and application thereof
CN109970679B (en) Paeonol thiazole derivatives and preparation method and application thereof
JPH04210946A (en) Novel aryl vinylamide derivative and method for producing the same
CN111606848A (en) A kind of preparation method of fluorodiphenyl substituted pyridine compounds
KR100830541B1 (en) Novel Chalcone Derivatives with Interleukin-5 Inhibitory Effect
CN107573336B (en) Benzoheterocycle-formamide-pyridone derivative and preparation method and application thereof
CN109020883B (en) A kind of 3-cyano-2-aminopyridine derivative and its preparation method and application
CN110483465B (en) Synthesis method of genistein bridged piperazine derivatives and application of genistein bridged piperazine derivatives in anti-tumor direction
CN101555248B (en) Method for preparing poly-substituted 1, 5-naphthyridine compound
CN105541715A (en) Polysubstituted pyridine-1 (2H) -ketone derivative and synthetic method and application thereof
Ivachtchenko et al. Synthesis and Biological Evaluation of Novel 5, 8‐Disubstituted‐2‐methyl‐2, 3, 4, 5‐tetrahydro‐1H‐pyrido [4, 3‐b] indoles as 5‐HT6 and H1 Receptors Antagonists
JPS59190974A (en) Production of 5-carbamoyl-6-methyl-4-substituted-1,2,3,4- tetrahydro-2-thioxopyrimidine
CN110872263A (en) A compound and preparation method and application
CN106866680B (en) A kind of 3- aryl-6-carboxyamide pyrazoles simultaneously [1,5-a] pyrimidines and its application
CN112250639B (en) Heterocyclic substituted arylamine compound and preparation method and application thereof
CN114560855B (en) Cycloalkyl carboxamide derivatives, preparation method and application thereof
CN109438358A (en) A kind of imdazole derivatives and application thereof
CN112028955B (en) Trimethoxylated arabinose triazole structure spiroisoxazole-pyrrolizine derivative and preparation method and application thereof
CN117603127A (en) Novel chalcone derivative containing nitrogen heterocycle, and preparation method and application thereof
CN108707153B (en) D-valine substituted maleimide derivative and preparation method and application thereof
CN109160902B (en) Asymmetric bisquinazoline Schiff base derivative for treating tumors and preparation and medical application thereof
CN107382941B (en) Flavone derivative and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB03 Change of inventor or designer information
CB03 Change of inventor or designer information

Inventor after: Shen Liqun

Inventor after: Lu Jiahao

Inventor after: Wu Aiqun

Inventor after: Lei Fuhou

Inventor after: Yao Xingdong

Inventor after: Li Wen

Inventor after: Yang Jun

Inventor after: Lai Wuji

Inventor after: Qi Wanling

Inventor before: Shen Liqun

Inventor before: Wu Aiqun

Inventor before: Lu Jiahao

Inventor before: Lei Fuhou

Inventor before: Yao Xingdong

Inventor before: Li Wen

Inventor before: Yang Jun

Inventor before: Lai Wuji

Inventor before: Qi Wanling

RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20200901